| Primary |
| Drug Use For Unknown Indication |
34.8% |
| Product Used For Unknown Indication |
32.8% |
| Helicobacter Infection |
3.7% |
| Pneumonia |
3.6% |
| Pyrexia |
2.8% |
| Bronchitis |
2.7% |
| Respiratory Tract Infection |
2.7% |
| Bronchopneumonia |
2.5% |
| Hypertension |
1.6% |
| Duodenal Ulcer |
1.5% |
| Lower Respiratory Tract Infection |
1.4% |
| Hiv Infection |
1.3% |
| Coronary Artery Disease |
1.2% |
| Depression |
1.2% |
| Duodenitis |
1.2% |
| Myocardial Ischaemia |
1.2% |
| Infection |
1.1% |
| Gastritis |
1.0% |
| Nasopharyngitis |
1.0% |
| Gastric Ulcer |
0.9% |
|
| Urticaria |
15.4% |
| Pruritus |
7.7% |
| Completed Suicide |
7.0% |
| Rash |
7.0% |
| Vomiting |
7.0% |
| Periorbital Oedema |
5.6% |
| Angioedema |
4.9% |
| Face Oedema |
4.2% |
| Jaundice |
4.2% |
| Myalgia |
4.2% |
| Toxic Epidermal Necrolysis |
4.2% |
| Eye Swelling |
3.5% |
| Hallucination |
3.5% |
| Nausea |
3.5% |
| Rhabdomyolysis |
3.5% |
| Tremor |
3.5% |
| Illusion |
2.8% |
| International Normalised Ratio Increased |
2.8% |
| Malaise |
2.8% |
| Prothrombin Level Decreased |
2.8% |
|
| Secondary |
| Drug Use For Unknown Indication |
24.6% |
| Helicobacter Infection |
9.0% |
| Product Used For Unknown Indication |
7.6% |
| Duodenal Ulcer |
5.6% |
| Hiv Infection |
5.4% |
| Bronchitis |
5.1% |
| Pyrexia |
4.7% |
| Pneumonia |
4.3% |
| Helicobacter Gastritis |
4.0% |
| Depression |
3.6% |
| Pain |
3.6% |
| Bronchopneumonia |
2.9% |
| Cardiac Failure |
2.5% |
| Dyspepsia |
2.5% |
| Hypertension |
2.5% |
| Parenteral Nutrition |
2.5% |
| Diabetes Mellitus |
2.4% |
| Duodenitis |
2.4% |
| Influenza |
2.4% |
| Thrombosis Prophylaxis |
2.4% |
|
| Quality Of Life Decreased |
7.2% |
| Renal Failure Acute |
7.2% |
| Ventricular Fibrillation |
7.2% |
| Hepatitis Fulminant |
6.0% |
| Jaundice |
6.0% |
| Rash |
6.0% |
| Rash Maculo-papular |
6.0% |
| Stevens-johnson Syndrome |
6.0% |
| Urticaria |
6.0% |
| Liver Disorder |
4.8% |
| Pharyngeal Oedema |
4.8% |
| Dyspnoea |
3.6% |
| Hepatitis Acute |
3.6% |
| Hypoglycaemia |
3.6% |
| Pruritus |
3.6% |
| Sepsis |
3.6% |
| Septic Shock |
3.6% |
| Tachypnoea |
3.6% |
| Thrombocytopenia |
3.6% |
| Toxic Epidermal Necrolysis |
3.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
17.0% |
| Drug Use For Unknown Indication |
14.8% |
| Pneumonia |
8.0% |
| Hypertension |
7.8% |
| Prophylaxis |
6.6% |
| Rheumatoid Arthritis |
6.1% |
| Helicobacter Infection |
4.7% |
| Pain |
3.9% |
| Cardiac Failure |
3.5% |
| Hiv Infection |
3.1% |
| Infection Prophylaxis |
3.1% |
| Chronic Obstructive Pulmonary Disease |
2.9% |
| Thrombosis Prophylaxis |
2.9% |
| Acute Coronary Syndrome |
2.7% |
| Epilepsy |
2.7% |
| Haemoptysis |
2.3% |
| Non-small Cell Lung Cancer |
2.0% |
| Pharyngitis |
2.0% |
| Sleep Disorder |
2.0% |
| Urinary Tract Infection |
2.0% |
|
| Pneumonia |
8.1% |
| Thrombocytopenia |
8.1% |
| Vomiting |
8.1% |
| Rhabdomyolysis |
7.0% |
| Colonic Stenosis |
5.8% |
| Septic Shock |
5.8% |
| White Blood Cell Count Increased |
5.8% |
| Diarrhoea |
4.7% |
| Shock |
4.7% |
| Stevens-johnson Syndrome |
4.7% |
| Vasculitis |
4.7% |
| Wrong Technique In Drug Usage Process |
4.7% |
| Diabetic Ketoacidosis |
3.5% |
| Personality Change |
3.5% |
| Purpura |
3.5% |
| Respiratory Failure |
3.5% |
| Sepsis |
3.5% |
| Sinus Tachycardia |
3.5% |
| Ventricular Fibrillation |
3.5% |
| Vertigo |
3.5% |
|
| Interacting |
| Product Used For Unknown Indication |
35.0% |
| Gastritis |
12.7% |
| Helicobacter Infection |
11.5% |
| Hyperlipidaemia |
4.5% |
| Hypertriglyceridaemia |
4.5% |
| Drug Use For Unknown Indication |
3.8% |
| Helicobacter Test Positive |
3.8% |
| Post Herpetic Neuralgia |
3.8% |
| Essential Hypertension |
3.2% |
| Personality Disorder |
2.5% |
| Pyrexia |
2.5% |
| Helicobacter Gastritis |
1.9% |
| Bacterial Infection |
1.3% |
| Bacterial Infection Due To Helicobacter Pylori (H. Pylori) |
1.3% |
| Brain Injury |
1.3% |
| Bronchopneumonia |
1.3% |
| Duodenitis |
1.3% |
| Epilepsy |
1.3% |
| Lobar Pneumonia |
1.3% |
| Pneumonia |
1.3% |
|
| Myopathy |
17.9% |
| Long Qt Syndrome |
7.1% |
| Myalgia |
7.1% |
| Parkinsonism |
7.1% |
| Syncope |
7.1% |
| Blood Pressure Decreased |
3.6% |
| Chills |
3.6% |
| Diarrhoea |
3.6% |
| Epilepsy |
3.6% |
| Helicobacter Infection |
3.6% |
| International Normalised Ratio Increased |
3.6% |
| Paresis |
3.6% |
| Renal Failure Acute |
3.6% |
| Rhabdomyolysis |
3.6% |
| Sedation |
3.6% |
| Shock |
3.6% |
| Torsade De Pointes |
3.6% |
| Urinary Tract Infection |
3.6% |
| Visual Acuity Reduced |
3.6% |
| Vomiting |
3.6% |
|
